CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: A systematic review and meta-analysis

BACKGROUND: CD133 is one of the most commonly used markers of cancer stem cells (CSCs), which are characterized by their ability for self-renewal and tumorigenicity. However, the clinical and prognostic significance of CD133 in gastric cancer remains controversial. To clarify a precise determinant o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiming, Li, Yunshan, Guo, Bo, Ma, Yu, Zang, Tao, Wei, Gengfang, Liang, Dexian, Fan, Shiqian, Cui, Jianli, Jiang, Juan, Tang, Zhinan, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747206/
https://www.ncbi.nlm.nih.gov/pubmed/26503471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747206/
https://www.ncbi.nlm.nih.gov/pubmed/26503471

Ejemplares similares